1-3 of 3
Thierry Rème, MD
Close
Sort by
Journal Articles

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Anja Seckinger, MD, Anna Jauch, PhD, Martina Emde, Susanne Beck, Marcel Mohr, Martin Granzow, PhD, Thomas Hielscher, Thierry Rème, MD, Reinhard Schnettler, Nassim Fard, Katrin Hinderhofer, Paul Theodor Pyl, Wolfgang Huber, PhD, Vladimir Benes, PhD, Anna Marciniak-Czochra, Véronique Pantesco, Anthony D. Ho, MD, Bernard Klein, Jens Hillengass, MD, Dirk Hose, MD
Journal: Blood
Blood (2016) 128 (22): 235.
https://doi.org/10.1182/blood.V128.22.235.235
Published: 2016
Journal Articles

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Michel Jourdan, PhD, Jerome Moreaux, PhD, Dirk Hose, MD, Jean-Francois Rossi, MD, PhD, Karène Mahtouk, PhD, Mathieu Aboulaze, Nicolas Robert, Marion Baudard, MD, PhD, Thierry Reme, MD, PhD, Angela Romanelli, Hartmut Goldschmidt, MD, Michel Dreano, PhD, Bernard Klein, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 3472.
https://doi.org/10.1182/blood.V108.11.3472.3472
Published: 2006
Journal Articles

The Human Plasma Cell Gene Expression Program.

John De Vos, MD, PhD, Dirk Hose, MD, PhD, Thierry Reme, MD, PhD, Hartmut Goldschmidt, MD, PhD, Jean-Francois Rossi, MD, PhD, Friedrich Cremer, MD, PhD, Bernard Klein, PhD
Journal: Blood
Blood (2004) 104 (11): 3242.
https://doi.org/10.1182/blood.V104.11.3242.3242
Published: 2004